Abstract:Hericium erinaceus, a consumable mushroom, has shown a potential to enhance the production of neuroprotective bioactive metabolites. Traumatic brain injury (TBI) often leads to cognitive, physical, and psychosocial impairments, resulting in neuroinflammation and the loss of cortical neurons. In this research, the effects of H. erinaceus mycelium, its derivative erinacine C, along with the underlying mechanisms, were examined in terms of oxidative stress modulation and neurological improvement in a rat model of mild traumatic brain injury (mTBI). Male Sprague-Dawley rats were administered diets containing H. erinaceus mycelium and erinacine C following experimental brain injury; these supplements were continued throughout the recovery phase. The binding activity of NF-E2-related factor 2 (Nrf2) near antioxidant genes in mixed glial cells was measured by chromatin immunoprecipitation-quantitative polymerase chain reaction (ChIP-qPCR). The motor beam walking test revealed that dietary supplementation of H. erinaceus mycelium resulted in modest improvements in spatial memory while inhibiting neuron cell death and microglial activation according to brain histological examination. These findings were further corroborated by the upregulation of several antioxidant enzymes (catalase, glutathione reductase, thioredoxin reductase, and superoxide dismutase) and phospho-CAMP-response element-binding (p-CREB) levels in the mTBI model treated with H. erinaceus mycelium. Erinacine C treatment led to significantly reduced brain inflammation and normalization of mTBI-induced deficits through the modulation of the Nrf2 activation pathway and upregulated expression of numerous Nrf2-binding antioxidant genes such as catalase, thioredoxin reductase, superoxide dismutase, and brain-derived neurotrophic factor. This study demonstrates the potential of H. erinaceus mycelium and erinacine C in facilitating recovery following mTBI, including the prevention of neuronal injury and inactivation of microglia through the Nrf2-mediated antioxidant pathway in vivo.

What problem does this paper attempt to address?

The paper primarily explores the neuroprotective effects and potential mechanisms of the mycelium of Hericium erinaceus and its derivative erinacine C in mild traumatic brain injury (mTBI). ### Research Background and Objectives: - Traumatic brain injury (TBI) can lead to long-term cognitive, physical, and psychosocial dysfunction, causing neuroinflammation and cortical neuron loss. - Mild traumatic brain injury (mTBI) is one of the most common types of TBI, with approximately 1.7 million cases reported annually. - The study aims to investigate the effects of Hericium erinaceus mycelium and its active component erinacine C on oxidative stress regulation and neurological function improvement in a rat model of mTBI, and to explore its mechanism of action through the Nrf2-dependent pathway. ### Main Research Content and Methods: - A modified weight-drop technique was used to establish an mTBI animal model. - The experimental group rats were given a diet containing Hericium erinaceus mycelium or erinacine C throughout the recovery period. - Chromatin immunoprecipitation-quantitative polymerase chain reaction (ChIP-qPCR) was used to measure the binding activity of NF-E2-related factor 2 (Nrf2) to antioxidant genes in mixed glial cells. - Behavioral tests were used to assess neurological function recovery, and histological examinations were conducted to evaluate neuronal cell death and microglial activation. - Changes in levels of various antioxidant enzymes (such as catalase, glutathione reductase, thioredoxin reductase, and superoxide dismutase) and phosphorylated cAMP response element-binding protein (p-CREB) were analyzed. ### Main Findings: - Dietary supplementation with Hericium erinaceus mycelium moderately improved spatial memory and inhibited neuronal cell death and microglial activation. - Erinacine C treatment significantly reduced brain inflammation and restored deficits caused by mTBI by regulating the Nrf2 activation pathway and upregulating the expression of various Nrf2-binding antioxidant genes (such as catalase, thioredoxin reductase, superoxide dismutase, and brain-derived neurotrophic factor). - These results suggest that Hericium erinaceus mycelium and erinacine C may help promote recovery after mTBI, including preventing neuronal damage and inactivating microglia through the Nrf2-mediated antioxidant pathway. In summary, this study experimentally demonstrated the potential neuroprotective effects of Hericium erinaceus mycelium and its derivative erinacine C in mild traumatic brain injury and elucidated the specific mechanisms by which they act through the Nrf2-dependent pathway.

The Cerebral Protective Effect of Novel Erinacines from Hericium erinaceus Mycelium on In Vivo Mild Traumatic Brain Injury Animal Model and Primary Mixed Glial Cells via Nrf2-Dependent Pathways

Neuroprotective Effects of (-)-epicatechin on Traumatic Brain Injury Mice by Nuclear Factor E2-related Factor 2 Pathway

Post-Treatment with Erinacine A, a Derived Diterpenoid of H. erinaceus, Attenuates Neurotoxicity in MPTP Model of Parkinson’s Disease

Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo

Erianin Promotes Endogenous Neurogenesis in Traumatic Brain Injury Rats

Hericium erinaceus and Coriolus versicolor Modulate Molecular and Biochemical Changes after Traumatic Brain Injury

The Neuroprotective Properties of Hericium erinaceus in Glutamate-Damaged Differentiated PC12 Cells and an Alzheimer’s Disease Mouse Model

Preclinical Bioavailability, Tissue Distribution, and Protein Binding Studies of Erinacine A, a Bioactive Compound from Hericium erinaceus Mycelia Using Validated LC-MS/MS Method

Hericium erinaceus Promotes Anti-Inflammatory Effects and Regulation of Metabolites in an Animal Model of Cerebellar Ataxia

Neuroprotective effects of Hericium erinaceus (Bull.: Fr.) Pers. against high-dose corticosterone-induced oxidative stress in PC-12 cells

Hericerin derivatives activates a pan‐neurotrophic pathway in central hippocampal neurons converging to ERK1/2 signaling enhancing spatial memory

Erinacine A-Enriched Hericium erinaceus Mycelium Produces Antidepressant-Like Effects through Modulating BDNF/PI3K/Akt/GSK-3β Signaling in Mice

N-acetylcysteine Amide Provides Neuroprotection Via Nrf2-ARE Pathway in a Mouse Model of Traumatic Brain Injury

Discovery of a New Compound, Erinacerin W, from the Mycelia of Hericium erinaceus, with Immunomodulatory and Neuroprotective Effects

Immunomodulatory protein from ganoderma microsporum protects against oxidative damages and cognitive impairments after traumatic brain injury

Hericium erinaceus potentially rescues behavioural motor deficits through ERK-CREB-PSD95 neuroprotective mechanisms in rat model of 3-acetylpyridine-induced cerebellar ataxia

Curcumin Provides Neuroprotection in Model of Traumatic Brain Injury Via the Nrf2-ARE Signaling Pathway

Hericium erinaceus Mycelium Ameliorates In Vivo Progression of Osteoarthritis

Reduced Neuroinflammation and Improved Functional Recovery after Traumatic Brain Injury by Prophylactic Diet Supplementation in Mice.

Correction To: Protective Effects of Chinese Herbal Medicine Rhizoma Drynariae in Rats after Traumatic Brain Injury and Identification of Active Compound

Elucidating the molecular mechanisms behind the therapeutic impact of median nerve stimulation on cognitive dysfunction post-traumatic brain injury